![](/img/cover-not-exists.png)
Failure of taxol-based combination chemotherapy for malignant glioma cannot be overcome by G2/M checkpoint abrogators or altering the p53 status
Raoul Borbé, Johannes Rieger, Michael WellerVolume:
44
Language:
english
Pages:
11
DOI:
10.1007/s002800050970
Date:
July, 1999
File:
PDF, 311 KB
english, 1999